Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules

Journal of Clinical Pathology

Volumn 56, Issue 8, 2003, Pages 631-633

  Sadahira, Y ^a   Notohara, K ^b   Manabe, T ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GRANZYME B; T CELL INTRACELLULAR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW; CASE REPORT; CELL INFILTRATION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; FIBROSIS; GENE REARRANGEMENT; HEPATOSPLENIC T CELL LYMPHOMA; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; LYMPHOMA CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; T CELL LYMPHOMA;

ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; GRANZYMES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLY(A)-BINDING PROTEINS; PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RNA-BINDING PROTEINS; SERINE ENDOPEPTIDASES; SPLENIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042090408     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.8.631     Document Type: Article

References (11)

1. Farcet JP Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoida localization of malignant cells expressing the T-cell receptor gamma delta. Blood 1990;75:2213-19.
2. Jaffe ES, Ralfkiaer E. Hepatosplenic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:210-11.
3. Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic αβT-cell lymphomas. Report of 14 cases and comparison with hepatosplenic γδT-cell lymphomas. Am J Surg Pathol 2001;25:285-96.
4. Anderson P, Nagler-Anderson C, O'Brien C, et al. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990;144:574-82.
5. Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 1996;88:4265-74.
6. Salhany KE, Feldman M, Kahn MJ, et al. Hepatosplenic gamma/delta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol 1997;28:674-85.
7. Khan WA, Yu L, Eisenbrey AB, et al. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Am J Clin Pathol 2001;116:41-50.
8. Gaulard P, Zafrani ES, Mavier P, et al. Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases. Hepatology 1986;6:864-8.
9. Sadahira Y, Ohmoto K, Yamamoto S, et al. Expression of cytotoxic molecule TIA-1 in malignant lymphomas mimicking fulminant hepatitis. Pathol Int 1998;48:695-704.
10. Sadahira Y, Akisada K, Sugihara T, et al. Comparative ultrastructural study of cytotoxic granules in nasal natural killer cell lymphoma, intestinal T-cell lymphoma, and anaplastic large cell lymphoma. Virchows Arch 2001;438:280-8.
11. Oshima K, Haraoka S, Harada N, et al. Hepatosplenic gamma/delta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology 2000;36:127-35.